Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lodoco cost?

See the DrugPatentWatch profile for Lodoco

What is “Lodoco,” and where are you seeing the price?

“Lodoco” could refer to different products (for example, a brand name for a medicine in some countries). Pricing depends heavily on the exact product, dosage/strength, pack size, and the country or pharmacy you’re using.

If you share one detail—either the full product name (as written on the box) or your country/state and the package size (e.g., tablets 10/20/30, syrup 100 ml, injection strength)—I can narrow down what “Lodoco” typically costs where you are.

How much does Lodoco usually cost (what drives the price)?

Prices vary most based on:
- The exact active ingredient and strength (different strengths often cost differently).
- Pack size (fewer units usually costs less overall but can have a higher per-unit price).
- Country and dispensing channel (community pharmacy vs hospital pharmacy vs online).
- Whether it’s branded or generic, and whether it’s covered by insurance or a local subsidy.

Is Lodoco available as a generic, and does that lower cost?

If Lodoco is a branded medicine, a generic version may be cheaper. Whether a lower-cost alternative is available depends on the active ingredient and local approvals.

If you tell me the strength and what it’s for (or send the label wording), I can help you identify possible generic equivalents to compare costs.

Where can you check the real-time price?

For the most accurate “current price,” check:
- The pharmacy website/app in your area
- Hospital pharmacy pricing (if applicable)
- Your country’s official drug price list (if one exists)

What I need from you to give an exact cost

Reply with:
1) Your country (and city/state if relevant)
2) The exact wording on the package (including strength, e.g., “X mg” or “X%”)
3) Pack size (e.g., 10 tablets, 30 tablets, 100 ml)
4) Whether you want price for a tablet/syrup/injection (whichever applies)

Then I can give you a more specific cost range and what that cost usually includes (per-pack vs per-dose).



Other Questions About Lodoco :

Agpeha lodoco patent? Does medicare cover lodoco?

AI-Drug Label Prescribing Information Alignment Report

96
96%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI response’s efficacy claim that LODOCO reduces risk of MI/stroke/cardiovascular death in adults is directly supported by the labeled indication in Section 1 and the LoDoCo2 composite endpoint description in Section 14.


Category Scores

Indication
100
Excellent
Dosage
90
Excellent

Accurate Statements

LODOCO reduces risk of MI/stroke/cardiovascular death in adult patients.
Section 1 Indications and Usage: “LODOCO is indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients…”; Section 14 Clinical Studies: composite includes “cardiovascular death… spontaneous (nonprocedural) myocardial infarction, ischemic stroke…”
The LoDoCo2 primary endpoint composite includes cardiovascular death, spontaneous (nonprocedural) myocardial infarction, and ischemic stroke.
Section 14 Clinical Studies: “The primary end point of LoDoCo2 trial was a composite of cardiovascular death, spontaneous (nonprocedural) myocardial infarction, ischemic stroke, or ischemia-driven coronary revascularization.”
0.5 mg once daily resulted in a 31% lower relative risk (RRR) of the primary composite endpoint versus placebo.
Section 14 Clinical Studies excerpt included in the prompt: “0.5 mg of colchicine once daily resulted in a 31% lower relative risk (RRR)…”

Unsupported Statements

“The exact components (MI, stroke, cardiovascular death) are explicitly included in the approved Indications (Section 1) and are also part of the efficacy composite endpoint described in Clinical Studies (Section 14).”
Supported as stated by the provided label excerpts; no unsupported content identified.

Contradictions


Important Omissions

No safety-related details (e.g., contraindications, warnings/precautions, drug interactions) were discussed in relation to this efficacy claim.
Importance: Low

Safety Assessment

Potential Patient Risk: Low
Evaluation is limited to an efficacy/indication claim; the response does not introduce safety instructions or risk claims not grounded in the provided label excerpts.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Minor: The response includes an 'unsupportedStatements' entry placeholder that is not actually unsupported; otherwise content is aligned with provided label excerpts.

Suggested Improvement
Avoid including unsupported/placeholder evaluation fields when the statement is supported, and keep the assessment strictly tied to provided label text.

Drug Brand Mention Assessment

Branding Score
18
Visibility
24
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • “Lodoco” could refer to different products
  • Pricing depends on the exact product, dosage/strength, pack size, and country or pharmacy you’re using
  • Prices vary based on active ingredient and strength, pack size, country/dispensing channel, and branded vs generic/coverage
Differentiators
  • Pricing is driven by exact active ingredient and strength
  • Pricing depends on pack size and dispensing channel
  • Whether it’s branded or generic and insurance/subsidy coverage affects cost

Pricing Perception: Not Mentioned